Day: July 23, 2024

HOLLYWOOD, Fla., July 23, 2024 (GLOBE NEWSWIRE) — NV5 Global, Inc. (the “Company” or “NV5”) (Nasdaq: NVEE), a provider of technology, conformity assessment, and consulting solutions, announced today that it has been awarded a $5 million contract by the National Oceanic and Atmospheric Administration (NOAA) Office of Coast Survey to conduct a comprehensive hydrographic survey in Lake Michigan. “NV5’s geospatial marine surveying business continues its strategic expansion into new geographies to support water resource management, maritime safety, and updated navigational information,” said Dickerson Wright, PE, Executive Chairman of NV5. “NV5’s specialized expertise in hydrographic surveying and nautical charting makes us uniquely qualified to support commercial and recreational maritime safety efforts by providing essential...

Conference call and webcast to be held the same day at 8:00 AM ET BRADENTON, Fla., July 23, 2024 (GLOBE NEWSWIRE) — First Watch Restaurant Group, Inc. (NASDAQ: FWRG) (“First Watch” or the “Company”), the leading Daytime Dining concept serving breakfast, brunch and lunch, today announced that it plans to release its second quarter 2024 financial results on Tuesday, August 6, 2024, before the market opens. A conference call and webcast will follow at 8:00 AM ET, hosted by Chris Tomasso, Chief Executive Officer and President, and Mel Hope, Chief Financial Officer. Interested parties may listen to the conference call via any one of three options:Dial 201-389-0914, which will be answered by an operator Pre-register by entering your information at this Call Me™ link Join the webcast at https://investors.firstwatch.com/news-and-events/eventsThe...

MINNEAPOLIS, July 23, 2024 (GLOBE NEWSWIRE) — Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), announced today the publication of the reimbursement of Inspire therapy in France. “We are thrilled to offer our clinically proven treatment option for moderate to severe OSA to patients and physicians in France,” said Tim Herbert, Chairman and Chief Executive Officer of Inspire. “Inspire therapy is backed by a strong body of evidence and years of clinical experience demonstrating the safety and efficacy of our therapy.” Inspire therapy received European Conformity Marking for commercialization in Europe in 2010. Since that time, the company’s approach has been...

Group to Advise on the Application of Ovid’s Novel Pipeline Programs to Broader Disorders of the BrainNeurologists/epileptologists Dr. Imad Najm of the Cleveland Clinic Neurological Institute and the Cleveland Clinic Epilepsy Center, and Dr. Raman Sankar, the Emeritus Chief of Pediatric Neurology at UCLA Health, appointed to Ovid’s Scientific Advisory Board (SAB) Neuroscientists Dr. Jamie Maguire of Tufts University and Dr. Jeff Noebels of Baylor College of Medicine, appointed to the SAB to contribute expertise in neurophysiology, hyperexcitability and network effects The SAB will advise on the potential application of Ovid’s compounds to broader disorders in which they may offer therapeutic promise, including brain conditions caused by hyperexcitability, neurovascular and neuro-inflammatory dysfunctionNEW YORK, July 23, 2024 (GLOBE...

Agreement to Expand into the Fastest Growing E-commerce Market in the World SHENZHEN, China, July 23, 2024 (GLOBE NEWSWIRE) — Jayud Global Logistics Limited (NASDAQ: JYD) (“Jayud” or the “Company”), a leading end-to-end supply chain solution provider based in Shenzhen, specializing in cross-border logistics, today announced a Strategic Cooperation Agreement (the “Agreement”) with Lazbao Group (“Lazbao”), a leading full-service e-commerce logistics service provider in Southeast Asia. The Agreement aims to establish future chartered air services from Jayud across Lazbao’s existing service areas in Southeast Asia. According to eMarketer, a market research company that provides insights and trends related to digital marketing, media, and commerce, the Southeast Asian market was the fastest-growing e-commerce...

Company to Host Investor Call on Tuesday, July 23, 2024, at 8.30 am ETRevenue achieved a record of $19.9 million, up 55.3% from $12.8 Million. Gross Profit Increased by 135.1% to $11.8 Million from $5.0 Million. Gross Margin Expanded to 59.3% from 39.2%. EPS Surged by 1537.9% to $0.37 from $0.02.BEIJING, July 23, 2024 (GLOBE NEWSWIRE) — Global Mofy Metaverse Limited (the “Company” or “Global Mofy”) (Nasdaq: GMM), a technology solutions provider engaged in virtual content production and the development of 3D digital assets for use in the broader digital content industry, today reported financial results for the six months ended March 31, 2024, with revenue, gross margin, and EPS all surging on a year-over-year basis to new company records. “The digital revolution is transforming industries worldwide,...

WARREN, N.J., July 23, 2024 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients’ lives through innovative science and delivery technologies, today announced that it will report results for the second quarter ended June 30, 2024 and provide an update on recent developments in its business after market close on Tuesday, August 6, 2024. Management will host a conference call for investors at 8:00 a.m. ET on Wednesday, August 7, 2024. In order to participate, please register in advance here to obtain a local or toll-free phone number and your personal pin. A live webcast of the call will be available on Aquestive’s website at: Second Quarter 2024 Earnings Call Following the call, a replay of the...